Please enable JavaScript.
Coggle requires JavaScript to display documents.
MAIA elements, Nolan has a high-risk non transplantable myeloma diagnosis…
-
Nolan has a high-risk non transplantable myeloma diagnosis since 2020. He have fatigue and loss of weight. BP, weight and heart rate information is fine
Nolan is being treated with daratumumab, lenalidomide and dexametasone. He looks pale and now is having blood on his faeces since one day ago. He received a t(11;14) report from his bone marrow sample.
Nolan´s doctor received a MAIA alert about haematological side effects from daratumumab and decides to use treatment decision algorithm based on the new genomic data
Nolan´s doctor decides to change his treatment to ixazomib + venetoclax based on genomic and side effects data
MAIA connects monitoring, follow up and adherence to Nolan´s and caregiver. Nolan also watch an ixazomib and venetoclax video about dosage and side effects